Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Catalyst Pharmaceutical Partners Inc buy BiotechBee

Catalyst Pharmaceutical Partners Inc
Start price
€20.76
23.02.25 / 70%
Target price
€35.00
31.01.27
Performance (%)
11.46%
End price
€23.14
30.03.25
Summary
This prediction ended on 30.03.25 with a price of €23.14. The prediction had a final performance of 11.46%. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m
Catalyst Pharmaceutical Partners Inc -0.396% -0.396%
iShares Core DAX® 0.734% 1.458%
iShares Nasdaq 100 -2.686% -0.146%
iShares Nikkei 225® -2.261% -2.729%
iShares S&P 500 -1.346% 0.467%

According to BiotechBee what are the pros and cons of Catalyst Pharmaceutical Partners Inc for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Prediction Buy
Perf. (%) 11.46%
Target price 35.000
Change
Ends at 31.01.27

Buy mit Kursziel 35,0

BiotechBee 
0
Report Share
23.02.25
In the thread Trading Catalyst Pharmaceutical Partners Inc
Prediction Buy
Perf. (%) 11.46%
Target price 35.000
Change
Ends at 31.01.27

Buy beendet

BiotechBee 
0
Report Share
30.03.25

Stopped prediction by BiotechBee for Catalyst Pharmaceutical Partners Inc

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€17.48
08.09.24
€21.00
30.04.27
18.14%
14.12.24

Could be very worthwhile Investment >20% year
BiotechBee 
08.09.24 70%